JCTR is proud to annouce the expansion of the editorial team

The following members have joined the editorial team of JCTR:

Prof. Andrew G. Lee.
Andrew G. Lee, MD is the Herb and Jean Lyman Centennial Chair in Ophthalmology and is the Founding Chairman of the Blanton Eye Institute, Department of Ophthalmology at Houston Methodist Hospital in Houston, Texas and is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medicine. He is adjunct professor of Ophthalmology at Baylor College of Medicine; Texas A and M College of Medicine; University of Iowa and the University of Buffalo; and Clinical Professor at the University of Texas Medical Branch in Galveston, Texas and the UT MD Anderson Cancer Center.

Prof. Marc Jeschke
Marc Jeschke , MD, PhD, FACS, FRCSC has been caring for burn patients and conducting research in the field of burns for over 20 years. He is a global leader in burn care, research, and education; according to Expertscape, he is the second highest-ranked expert in burns in the world. Dr. Jeschke was Director of the Ross Tilley Burn Centre at Sunnybrook Health Sciences Centre from 2010 to 2021. He is a Surgeon Scientist and a Professor in the Departments of Surgery and Immunology at the University of Toronto. He also is the Director of the Translational Research Committee for the Department of Surgery at the University of Toronto. As of July 4, 2022, Dr. Jeschke will become the VP of Research and Head of the Burn Program, at Hamilton Health Sciences Centre and McMaster University.

Prof. Khalid Siddiqui
Khalid Siddiqui, PhD is associate professor and researcher at the Strategic Center for Diabetes Research of College of Medicine, King Saud University Riyadh, Saudi Arabia.

Prof. Shuqun Cheng
Shuqun Cheng Md, PhD is a hepatic surgen at Eastern Hepatobiliary Surgery Hospital in Shanghai, China.He was honoured by Chang Jiang Scholar in 2012 and Distinguished Young Scientist for The China National Funds in 2011. As a hepatic surgeon, he did almost 400 operations for liver cancer resection every year. His main contribution focused on the proposing a new Portal Vein Tumor Thrombosis (PVTT) classification and early antiviral therapy for guiding the surgical treatment for Hepatocellular carcinoma (HCC) and established PVTT cell lines for HCC metastasis study.

Dr. Sumanta Saha
Sumanta Saha is a doctor and epidemiologist from India. He is presently a teaching faculty at the Dept. of Community Medicine, R. G. Kar Medical College, Kolkata, India. His research interests include both communicable and non-communicable diseases. He has publications on various health topics, including pediatric infectious diseases, antenatal and perinatal issues, diabetes, and COVID-19.

Dr. Tony Kleijn
Tony Kleijn is a pathology resident at the University Medical Center Groningen (UMCG). He is on the board of the National Pathology Assistants Association (LPAV) to represent the interests of dutch AIOS, and is also involved in various training and (international) research projects of the UMCG.

Prof. Vikrant Rai
Vikrant Rai is an Assistant Professor in the Department of Translational Research at the Western University of Health Sciences, Pomona, CA. His research interests are investigating inflammatory molecular pathologies underlying various chronic inflammatory diseases and delineating immunomodulation and immunotherapeutic strategies.

JCTR's statement on "paid citations" reported by Retraction Watch

At the end of September, the editorial team of JCTR in Singapore received inquiries from authors regarding cash remuneration for researchers who cite articles published in JCTR in their own papers. This practice was addressed in a recent publication on the Retraction Watch website under the title “Publisher offers cash for citations". This incident was addressed to editor-in-chief and managing editor of JCTR on October 8th.

The editorial board of JCTR attests that none of the in-house editors and journal staff were cognizant of these practices up until October 8th. The editors and journal staff were never involved in any fashion in gaming the metrics for any purpose, and specifically for purposes of citation gauging. We strongly condemn such unethical practices and will never engage in such acts. Accordingly, JCTR will not entertain cash requests from individuals who claim to have cited our articles, nor shall we provide any payment for citations to JCTR articles.

Key editorial staff members convened on October 10th to properly resolve this issue. We have learned that JCTR was listed as "related journal" on Innoscience website for 10 months until mid-August. These unauthorized campaign operations by Innoscience with respect to JCTR were ceased immediately. JCTR did not and will never provide financial support or any means of support to such unauthorized campaign acts.

We would also like to clarify that our editorial decisions on submissions, selection of editorial board members, and the integrity of published articles are not affected by the commercial entities that were formerly associated with the campaign.

Michal Heger, editor-in-chief

Journal of Clinical and Translational Research

October 10, 2021